GLP-one course compounds. Semaglutide, tirzepatide, and liraglutide are authorised medicinal items within the Netherlands and carry elevated regulatory and import scrutiny. Any framing that offers them as therapeutic options to prescription medicines delivers them underneath the Geneesmiddelenwet and its advertising principles, which the IGJ active